http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1032429-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d3b6e03a92d64f0e4893a8b297f7647 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 1998-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc8eac994f9ef99cc6f8e0251c5db3f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a722c5a5a800ed26a42586ddf2af97c |
| publicationDate | 2003-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1032429-B1 |
| titleOfInvention | A method for in vivo dna delivery using a needle free apparatus |
| abstract | The present invention relates to the use of a solution comprising a non-infectious DNA molecule able to express in a mammal, a physiologically active protein, for the manufacture of a medicament intended to be delivered mainly to the mammalian skin using a needle-free apparatus adapted to this effect. The physiologically active protein can be an antigen that is (i) specific for a microorganism able to induce an infection in a mammal or (ii) tumor-associated; in this case the medicament is for treating or preventing an infection or a tumor disorder. The protein can also be a mammalian protein able to treat a genetic defect e.g., factor XIII or IX; or a cytokine. |
| priorityDate | 1997-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 235.